Natriuretic Peptide A (NPPA) (Middle Region) Peptide
Quick Overview for Natriuretic Peptide A (NPPA) (Middle Region) Peptide (ABIN8106216)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- NPPA Peptide - middle region
-
Sequence
- EVSPAQRDGG ALGRGPWDSS DRSALLKSKL RALLTAPRSL RRSSCFGGRM
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti- PRKACA Antibody (ARP80859_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- NPPA (Natriuretic Peptide A (NPPA))
-
Background
-
Background Information: The protein encoded by this gene belongs to the natriuretic peptide family. Natriuretic peptides are implicated in the control of extracellular fluid volume and electrolyte homeostasis. This protein is synthesized as a large precursor (containing a signal peptide), which is processed to release a peptide from the N-terminus with similarity to vasoactive peptide, cardiodilatin, and another peptide from the C-terminus with natriuretic-diuretic activity. Mutations in this gene have been associated with atrial fibrillation familial type 6. This gene is located adjacent to another member of the natriuretic family of peptides on chromosome 1.
Alternative Symbols: ANF, ANP, CDD, CDP, PND, ATFB6, ATRST2, CDD-ANF
-
Molecular Weight
- 16 kDa
-
Gene ID
- 4878
-
NCBI Accession
- NP_006163
-
UniProt
- P01160
Target
-